Ftse Mib
33.629,21
-0,32%
DAX
18.001,60
0,54%
S&P 500
5.127,79
1,26%
NASDAQ
16.156,33
1,99%
Bitcoin
63.247,62
0,57%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Fulgent Genetics Inc (FLGT) Fulgent Genetics Inc (FLGT) Notizie

Fulgent Genetics Inc

FLGT
21,50
0,26 (1,22%)
04 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
03/5/202413:00BWFulgent Reports First Quarter 2024 Financial Results
11/4/202422:05BWFulgent Genetics to Announce First Quarter 2024 Financial..
05/3/202422:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202422:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202401:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202401:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202413:08EDGAR2Form 8-K - Current report
28/2/202413:00BWFulgent Reports Fourth Quarter and Full Year 2023 Financial..
28/2/202400:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202400:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202414:00BWFulgent Genetics to Announce Fourth Quarter and Full Year..
10/2/202400:09EDGAR2Form 5 - Annual statement of changes in beneficial ownership..
09/2/202414:31PRNUSCord Blood Registry® (CBR®) by CooperSurgical® and Fulgent..
07/2/202401:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202422:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/1/202422:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/1/202422:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/12/202302:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202303:43EDGAR2Form 144 - Report of proposed sale of securities
07/12/202300:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202323:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202300:13EDGAR2Form 144 - Report of proposed sale of securities
05/12/202300:12EDGAR2Form 144 - Report of proposed sale of securities
20/11/202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/11/202303:21EDGAR2Form 144 - Report of proposed sale of securities
14/11/202322:30BWFulgent to Participate in the Piper Sandler 35th Annual..
07/11/202323:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/11/202321:05BWFulgent Shares Data from Two Poster Presentations at SITC..
03/11/202312:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/11/202312:09EDGAR2Form 8-K - Current report
03/11/202312:00BWFulgent Reports Third Quarter 2023 Financial Results
01/11/202322:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/10/202322:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/10/202322:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/10/202314:00BWFulgent Announces Two Poster Presentations at SITC 2023..
17/10/202314:00BWFulgent Genetics to Announce Third Quarter 2023 Financial..
11/9/202322:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/9/202322:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/9/202301:00EDGAR2Form 144 - Report of proposed sale of securities
21/8/202322:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/8/202322:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/8/202322:54EDGAR2Form 144 - Report of proposed sale of securities
16/8/202322:51EDGAR2Form 144 - Report of proposed sale of securities
07/8/202323:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/8/202313:07EDGAR2Form 8-K - Current report
04/8/202313:00BWFulgent Reports Second Quarter 2023 Financial Results
03/8/202323:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/8/202323:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/7/202322:05GLOBEExagen Inc. Appoints Paul Kim to Board of Directors
18/7/202314:00BWFulgent Genetics to Announce Second Quarter 2023 Financial..
Apertura: 20,50 Min: 20,50 Max: 21,60
Chiusura: 21,24

La tua Cronologia

NASDAQ
FLGT
Fulgent Genetics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network